• News
    • Opinion Editorial
    • Videos
    • Podcasts
  • Community
    • Members
  • Discussion
  • Groups
    • View All
    • Why Join?
  • Write for us
    Sign in Sign up


    • News
      • Opinion Editorial
      • Videos
      • Podcasts
    • Community
      • Members
    • Discussion
    • Groups
      • View All
      • Why Join?
    • Write for us
    Sign in Sign up

    Tag: Sepsis

    India’s CSIR Greenlight to Study Sepsis Drug in COVID-19 Patients

    India’s CSIR Greenlight to Study Sepsis Drug in COVID-19 Patients

    India’s Council of Scientific and Industrial Research (CSIR) seek creative ways to combat the novel coronavirus known as COVID-19. They suspect that Sepsivac—a commercial drug used…

    TrialSite Staff
    TrialSite Staff April 24, 2020
    1 Comment
    Cincinnati Children’s Hospital Investigators Develop PERSEVERE to Predict Mortality Levels from Sepsis

    Cincinnati Children’s Hospital Investigators Develop PERSEVERE to Predict Mortality Levels from Sepsis

    Cincinnati Children’s Hospital Medical Center investigators have developed a new rapid blood assay that can predict mortality risk levels from sepsis and could help inform…

    TrialSite Staff
    TrialSite Staff November 19, 2019
    0 Comments
    University College London Hospitals Collaborates With Mologic in Major Clinical Trial for Early Sepsis Detection

    University College London Hospitals Collaborates With Mologic in Major Clinical Trial for Early Sepsis Detection

    University College London Hospitals (UCLH) and Mologic, Ltd, a UK-based diagnostic technology firm, are collaborating on a major clinical trial that evaluates the sponsor’s point-of-care…

    TrialSite Staff
    TrialSite Staff September 15, 2019
    0 Comments
    Sepsis Study

    University of Pittsburgh Big Data Research Reveals Hidden Subtypes of Sepsis

    Much like cancer, sepsis isn’t simply one condition, but rather many conditions that could benefit from different treatments, according to the results of a University…

    TrialSite Staff
    TrialSite Staff May 20, 2019
    0 Comments

    Cheetah Medical Successfully Completes Key Sepsis Clinical Trial

    Cheetah Medical completed its enrollment for the Fluid Responsiveness Evaluation in Sepsis-associated Hypotension (FRESH) trial following successful primary outcomes. The FRESH study was led by…

    TrialSite Staff
    TrialSite Staff March 15, 2019
    0 Comments
    Sepsis

    University of Strathclyde Sepsis Diagnostic Technology Could Save Thousands of Lives in UK Alone

    UK researchers from Glasgow Scotland’s University of Strathclyde as well as University of Leeds and Paisley’s Royal Alexandra Hospital report on sepsis test device that…

    TrialSite Staff
    TrialSite Staff February 19, 2019
    0 Comments

    St. Jude Identifies Method to Reduce Risk of Brain Damage in Leukemia Survivors

    MDLinx reports that children with acute lymphoblastic leukemia (ALL) are at an extremely high risk of sepsis compared to the general population. In the first-published…

    TrialSite Staff
    TrialSite Staff September 26, 2018
    0 Comments

    Vanderbilt University Medical Center Research Fatal Toxicity with Immunotherapy Increasing

    Pam Harrison of Medscape reports that Fatal toxic effects from immune checkpoint inhibitors (ICIs) are rare, but clinicians need to be aware of the diverse…

    TrialSite Staff
    TrialSite Staff September 18, 2018
    0 Comments

    Patients with Sepsis Face Higher Risk of Stroke, Heart Attack Post Hospital Discharge

    Patients with sepsis are at increased risk of stroke or myocardial infarction (heart attack) in the first 4 weeks after hospital discharge, according to a…

    TrialSite Staff
    TrialSite Staff September 12, 2018
    0 Comments

    Harvard Designed CLOVERS Study Faces Challenges from Public Citizen

    Consumer advocacy group Public Citizen has filed a complaint with the federal government to stop the Massachusetts General Hospital sponsored CLOVERS Study—see link for study.…

    TrialSite Staff
    TrialSite Staff August 30, 2018
    0 Comments
    Load More

    Read more about…

    Alzheimer Alzheimer's Disease Artificial Intelligence Autoimmune Disease Breast Cancer Cancer Cardiovascular Challenging Results China Clinical Research Clinical Research as a Care Option Clinical Trials CNS Coronavirus covid-19 COVID-19 Dementia Diabetes Digital Health Digital Media FDA Gene Therapy Immunotherapy India Investigator Content Investigator Profiles Investor Watch Ivermectin Leading Pharma Leading Sites Neurology NIH Oncology Patient Recruitment Pharma Watch Positive Results Price Watch Prostate Cancer Research SARS-CoV-2 Site Challenges Site Success Site Watch UK Vaccine

    About Us

    TRIALSITE NEWS IS  DEDICATED TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

    © 2021 - Trial Site News
    • Terms of Service
    • Privacy Policy

    TrialSite News
    159 W Broadway, Suite 200
    Salt Lake City, UT 84101

    Report Content

    Harassment or bullying behavior
    Contains mature or sensitive content
    Contains misleading or false information
    Contains abusive or derogatory content
    Anything overly promotional selling products or services

    Block Member?

    Please confirm you want to block this member.

    You will no longer be able to:

    • See blocked member's posts
    • Mention this member in posts
    • Invite this member to groups
    • Message this member
    • Add this member as a connection

    Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.